OEOleg Radievich Esin

Oleg Radievich Esin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oleg Radievich Esin has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cerebral amyloid angiopathy

    by R.G. Esin, E.A. Gorobets, D.M. Efimova, O.R. Esin

    Cerebral amyloid angiopathy (CAA) is characterized by beta-amyloid deposition within cerebral blood vessels and constitutes an age-related vascular pathology associated with intracerebral hemorrhages and cognitive impairment. CAA is a major contributor to a subtype of stroke with high mortality, morbidity, and recurrence rates. The sporadic, familial, and iatrogenic variants of CAA have distinct epidemiological profiles. Inflammatory mechanisms exacerbate amyloid-induced vascular injury and may cause a distinct subtype of CAA-related inflammation. In 2022, an international collaborative study updated and validated the Boston Diagnostic Criteria (Version 2.0) for CAA across the full spectrum of clinical manifestations. Cognitive impairment in CAA generally manifests in three types: gradual functional decline, stepwise functional decline, and rapidly progressive cognitive deterioration associated with inflammation. CAA is strongly associated with Alzheimer’s disease (AD). While both conditions involve amyloid-β (Aβ) accumulation, their anatomical distributions differ. In AD, Aβ deposits mostly in the frontal and parietal association cortices. CAA is observed in approximately 90% of AD cases, and the coexistence of AD and CAA correlates with more severe disease progression.

  • Open Access

    Restless legs syndrome: Pathogenesis, diagnosis, treatment

    by R. G. Esin, E. A. Gorobets, O. R. Esin, E. N. Akbasheva, Р. Г. Есин, Е. А. Горобец, О. Р. Есин, Э. Н. Акбашева

    Restless Legs syndrome (RLS) occurs in about 3% of adults worldwide. RLS is still poorly diagnosed including due to the lack of screening tools based on verbal descriptors. A literature review was conducted using the eLibrary.ru, CyberLeninka, PubMed, Scopus, and Google Scholar databases, based on the keywords “restless legs syndrome”, “pathogenesis”, “diagnosis”, and “reatment”. The search covered a 25-year period. The gathered information was analyzed, systematized, and presented in the following sections: iron deficiency and RLS, genetic predisposition to RLS, the dopaminergic system and RLS, other risk factors and associated conditions, the clinical presentation of RLS, diagnostic criteria for RLS, and RLS treatment. RLS is commonly associated with iron deficiency. There is evidence of a genetic predisposition to RLS. Dopaminergic pathology in RLS is confirmed by the effectiveness of dopaminergic treatment, however, it can cause the phenomenon of augmentation – iatrogenic deterioration, which is characterized by an earlier onset of symptoms in the afternoon than before treatment, the spread of symptoms to the upper extremities and a decrease in the latency period before symptoms appear during periods of rest. Pharmacotherapy (high evidence strength) includes: gabapentin, gabapentin enacarbil, pregabalin, intravenous iron carboxymaltose. Conditionally recommended: intravenous low-molecular-weight iron dextran, ferumoxytol, iron sulfate, dipyridamole, delayed-release oxycodone or other opioids, peroneal nerve stimulation. Drugs that should not be prescribed as standard treatment: levodopa, pramipexole, transdermal rotigotine, ropinirole (can be used to treat RLS in patients who attach more importance to reducing RLS with short-term use and less importance to side effects with prolonged use (especially augmentation)).

  • Vestibular cortex and vestibular agnosia

    by R.G. Esin, O.R. Esin, L.R. Sakhapova

    This review analyzes recent literature on the structure of the vestibular cortex. Researchers have identified at least ten brain regions that respond to vestibular stimulation. The vestibular regions identified by caloric, galvanic, and auditory vestibular stimulation are mainly located deep in the lateral sulcus and in the perisylvian cortex around the sylvian fissure. They are also found in the primary somatosensory, posterior parietal, frontal, extrastriate cortex, the cingulate gyrus, and the hippocampus. Together, these regions form the vestibular cortex, a broad network of multisensory regions. Vestibular agnosia as a clinical phenomenon was described in 2021. It is characterized by a decrease or lack of perception of one’s own movements after vestibular stimulation, but normal vestibular reflexes are intact. Possible mechanisms for the development of vestibular agnosia are discussed.

  • Headache in cerebrovascular diseases

    by R.G. Esin, E.A. Gorobets, Yu.V. Laykova, O.R. Esin

    Headache is a common symptom of cerebrovascular diseases. This paper presents a literature review with a search depth of 20 years on the clinical features of headache as a criterion for diagnosing or raising clinical suspicion of acute or chronic cerebrovascular disease. The authors studied the most common diseases in clinical practice, focusing on headache causes in the «Headache attributed to cranial or cervical vascular disorder» section of the International Classification of Headache Disorders (3rd edition, 2018). Headaches of various origins are considered: associated with ischemic stroke, thrombosis of the main artery, cerebellar stroke, subarachnoid hemorrhage, arteritis; arising from a transient ischemic attack, with an unruptured arterial aneurysm of the brain, with dissection of the cervical-cephalic arteries, with thrombosis of the veins and sinuses of the brain, with reversible cerebral vasoconstriction syndrome; caused by non-traumatic intracerebral hemorrhage, as well as genetic vasculopathy. The features of the headache assessment in patients with cognitive impairment are addressed.

  • Epidemiology and some clinical aspects of primary headaches in children and adolescents

    by O.R. Esin, A.I. Mashtakova

    Headache (HA) is the most common neurological disorder in adults and one of the leading causes of disability in the world. In children and adolescents, HA has a significant impact on their physical and psychological state. This paper presents a literature review using eLibrary.ru, CyberLeninka, PubMed, Scopus, Embase, MEDLINE, Web of Science, Cochrane, and Google Scholar databases with the keywords «headache», «migraine», «tension headache», «children», «adolescents», «treatment», and «prevention». Primary headaches (PHAs) in children and adolescents are a polyetiological clinical phenomenon, resulting from the interaction of genetic, environmental, and cultural factors. PHAs require an integrative approach that combines pharmacological and non-pharmacological therapies. Identifying and modifying psychosocial triggers, optimizing nutrition, adjusting physical activity levels, and considering genetic and hormonal factors are key elements in developing effective strategies for the prevention and management of PHAs in children.

  • Chronic traumatic encephalopathy

    by R.G. Esin, E.A. Gorobets, O.R. Esin, A.I. Mashtakova

    Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease caused by repetitive head impacts from contact sports, physical violence, and other causes. The urgency of the problem is due to the high incidence of pathology, not only in adults, but, most importantly, in the pediatric population. The paper presents a review of the literature in databases eLibrary.ru, CyberLeninka, PubMed, Scopus and Google Scholar with the key terms «head injury», «traumatic encephalopathy», «diagnosis», «treatment», «children and adolescents». The information obtained is analyzed, systematized and presented in three sections: general information about CTE; sports-related concussion; clinical and morphological picture of CTE; diagnostic criteria for traumatic encephalopathy syndrome; treatment of CTE. Neurofibrillary glomeruli (phospho-tau) formation, impaired amyloid beta elimination, impaired blood-brain barrier function, and low-intensity inflammation play an important role in the pathogenesis of CTE. The agreed diagnostic criteria for traumatic encephalopathy syndrome and the step-by-step diagnosis of this syndrome proposed in 2021 by the National Institute of Neurological Disorders and Stroke of the USA are outlined. Treatment includes symptomatic therapy for anxiety and depression, cognitive impairment, behavioral disorders, neuroprotectors, and non-drug intervention methods. Citicoline (Neipilept) and choline alfoscerate (Cereton) are considered as potential neuroprotectors.


  • Cardiogenic dementia

    by R.G. Esin, E.A. Gorobets, A.I. Mashtakova, O.R. Esin

    Generally, when discussing vascular diseases of the brain, practitioners refer to diseases of the large (cervicocephalic) and small (perforating) arteries, requiring a differentiated approach to diagnosis, treatment, and prevention. The anatomical and functional unity of the cardiovascular system makes this approach quite arbitrary. Unfortunately, it often escapes attention that the most important component of the cardiovascular system (heart) and its diseases play an important, often dominant role in the development of cerebrovascular disorders, including cognitive impairment and dementia. This paper presents a literature review spanning a 50-year search depth. A literature search was conducted in the eLibrary.ru, CyberLeninka, PubMed, Scopus, and Google Scholar databases using the key terms «myocardial infarction», «heart failure», «myocardial disease», «cognitive impairment», and «dementia». Current evidence suggests a much broader understanding of the pathogenesis of a condition that was dubbed «cardiogenic dementia» almost half a century ago. The mechanisms underlying the development of encephalopathy in myocardial diseases include chronic brain hypoperfusion, chronic low-intensity inflammation, oxidative stress, damage to the blood-brain barrier, and hyperactivation of the renin-angiotensin-aldosterone system and the sympathetic nervous system.

  • Open Access

    Insomnia is a significant factor in cognitive impairment: Literature review and clinical observation

    by R. G. Esin, A. I. Mashtakova, O. R. Esin, L. R. Sakhapova

    The work presents an analysis of the current literature on the effect of insomnia on cognitive functions. The search was carried out using the databases of RSCI, Russian Medicine, Embase, Medline, Scopus, Web of Science, Google Scholar, using the keywords: insomnia, sleep disorder, cognitive functions, memory, functional MRI, treatment of insomnia, doxylamine. The search depth was 40 years. The consequences of sleep disorders include effects on chromosome telomeres, decreased neuron activation, and impaired brain connectivity. Insufficient sleep alters the activity of cortical neurons in areas responsible for cognitive functions, disrupts the functional connection between brain regions mediating executive functions, memory, and emotion regulation. Glymphatic clearance plays an important role in the pathogenesis of Alzheimer’s disease, as the vast majority of toxic metabolites are eliminated during sleep, and dementia is associated with sleep disorders along with age-related decreased aquaporin-4 function. The accumulation of toxic metabolites (including amyloid-β) begins at a young age and is associated with a shortening of sleep duration. Non-drug sleep improvement measures include behavioral correction: learning sleep habits, optimizing sleep conditions and improving sleep patterns, moderate physical activity during the day, and correcting environmental factors. In case of insomnia, central histamine H1 receptor blockers may be prescribed. Doxylamine is a drug used to treat nausea and vomiting in pregnant women, allergic rhinitis, and insomnia. Valocordin®-Doxylamine is a safe and effective over-the-counter medication that can benefit the patient with minimal side effects if used correctly.

  • Open Access

    The role of postural factors in the pathogenesis of tension-type headache in children

    by O. R. Esin, I. Kh. Khayrullin, И. Х. Хайруллин

    Introduction. Primary headaches (PH), including tension-type headache (TTH), have a strong negative impact on the quality of life and academic success of children. Posture disorders, particularly upper crossed syndrome (UCS), play an important role in the development and chronicization of TTH.Aim. To study the influence of UCS on the clinical picture of TTH in children and the effectiveness of non-pharmacological methods of correction.Materials and methods. A total of 113 children aged 14–17 years were examined. Frequent or chronic TTH with the presence of UCS was diagnosed in 70 children (main group), 43 children with infrequent TTH or without headache without TTH were included in the control group. Examination included history taking, neurological examination, posture assessment with laser leveler and mechanoalgometry. Treatment included kinesiotaping and training of correct motor stereotype.Results. Patients with UCS showed significantly greater forward head tilt angle, asymmetry of the shoulder girdle, decreased pain threshold of pericranial muscles, increased frequency and intensity of headache compared to controls (p < 0.001). Three months after treatment, there was a statistically significant decrease in head tilt angle, asymmetry of the shoulder girdle, increase in pain threshold and decrease in headache intensity and frequency (p < 0.001) to the level of the control group.Conclusions. UCS is a significant factor in the development and chronicization of TTH in children. Non-medicamentous correction with kinesiotaping and training in correct motor stereotypes are effective in restoring normal posture and reducing clinical manifestations of TTH.

  • Open Access

    GABAergic system – physiological role and clinical significance

    by O. R. Esin, A. I. Mashtakova, R. G. Esin

    This work presents a review of the literature using the elibrary.ru, CyberLeninka, PubMed, Scopus and Google Scholar databases with the key terms “Gamma-aminobutyric acid (GABA)”, “GABA agonists”, “GABA antagonists”, “GABA pathophysiology”, “children and adolescents”. The information obtained was analyzed, systematized and presented in three sections: general aspects of GABA, pathophysiology of GABA and GABAergic pharmacology and therapy. Currently, three types of GABA receptors have been identified: two fast-acting GABA-A and GABA-C and one slow-acting GABA-B. GABA is a neurotransmitter and neuromodulator of the autonomic nervous system, a hormone and trophic factor in endocrine organs, including the pituitary gland, pancreas, adrenal glands, uterus, ovaries, placenta and testes. Disturbance of GABA signaling is a pathophysiological link in diseases of the cardiovascular system, gastrointestinal tract, endocrine diseases (diabetes mellitus, diseases of the adrenal glands and reproductive organs). The GABA system of the autonomic nervous, endocrine and immune systems is being intensively studied for drug treatment of functional disorders of these systems. GABA acts not only as a neurotransmitter, its role as a neurohormone, trophic factor and immunomodulator has been established, which makes it a multifunctional molecule. In neurology, GABAergic drugs are used to treat paroxysmal disorders, including periodic syndromes of childhood, sleep disorders, complications of alcoholism, spasticity, acute and chronic pain, anxiety disorders and depression. The authors consider the therapeutic possibilities of aminophenylbutyric acid hydrochloride and its encapsulated form (Anvifen) in the treatment of neurological disorders and especially in pediatric practice. In view of the restrictions on the use of antidepressants and anxiolytics in children and adolescents, aminophenylbutyric acid hydrochloride is an effective and safe drug of choice in pediatric practice. The authors present the results of clinical observations of the drug’s effectiveness and safety.